intelligence360
  • About us
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Newton Massachusetts based Cupixel is raising $8,534,654.00 in New Equity Investment.

Newton Massachusetts based Cupixel is raising $8,534,654.00 in New Equity Investment.

June 15, 2022 Craig Etkin

Newton, MA – According to filings with the U.S. Securities and Exchange Commission, Cupixel is raising $8,534,654.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Elad Katav played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cupixel
Cupixel is a live and on-demand creativity platform aspiring to be a leading lifestyle brand for creative experiences. By fusing state-of-the-art technology, fresh content – led by artists, and high-end art tools, we enable anyone to create stunning works of art regardless of age or artistic skill. We use AR (smart tracing) and AI (photo transformation) to ensure a fail-proof, empowering, and enjoyable creativity time.

To learn more about Cupixel, visit http://cupixel.com/

Contact:
Elad Katav, Chief Executive Officer
508-596-3790
elad@cupixel.com
https://www.linkedin.com/in/eladkatav/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved


Venture Capital
1120, Boston, Cupixel, Massachusetts, Newton, Venture Capital

Post navigation

NEXT
New York City based Emissary is raising $5,000,000.00 in New Equity Investment.
PREVIOUS
Eli Lilly and Company to spend $2,100,000,000.00 to expand into new space in Lebanon Indiana.
Comments are closed.

Categories

Recent Posts

  • Epsilon Industries plans new project in Tuscaloosa, Alabama August 12, 2026
  • Electra plans new project in Springfield, Ohio August 12, 2026
  • BeOne Medicines plans new project in Hopewell, New Jersey August 11, 2026
  • Doncasters plans new project in Auburn, Alabama August 11, 2026

Archives

© 2026   Copyright SI360 Inc. All Rights Reserved.